Related Experiment Video

Updated: Apr 21, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

13.9K

From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration

Yang Zhao1, Cheng-Xin Gong

  • 1Department of Neurology, The First Hospital of Jilin University, Xinmin Street, Changchun, 130021, Jilin, China, youngzhao.jlu@foxmail.com.

Cellular and Molecular Neurobiology
|October 30, 2014
PubMed

Insights

Chronic cerebral hypoperfusion (CCH) contributes to neurodegeneration and dementia, including Alzheimer's disease (AD). Understanding CCH mechanisms is key to developing treatments for these conditions.

Area of Science:

  • Neuroscience
  • Cerebrovascular Medicine
  • Pathology

Background:

  • Chronic cerebral hypoperfusion (CCH) is linked to cerebrovascular disorders.
  • CCH plays a significant role in neurodegeneration and dementia, such as Alzheimer's disease (AD) and vascular dementia.

Purpose of the Study:

  • To review recent advances in understanding CCH-induced neurodegeneration and AD pathology.
  • To explore the mechanisms linking CCH to Alzheimer's-like pathology and cognitive decline.

Main Methods:

  • Review of recent scientific literature on CCH.
  • Discussion of CCH causes, assessment, and animal models.
  • Analysis of molecular and cellular mechanisms of CCH-induced neurodegeneration.

Main Results:

  • CCH promotes neurodegeneration and AD through multiple pathways.
  • Mechanisms include oxidative stress, Aβ accumulation, tau hyperphosphorylation, synaptic dysfunction, neuronal loss, white matter lesions, and neuroinflammation.
  • Animal models demonstrate CCH's impact on brain pathology and cognitive function.

Conclusions:

  • CCH is a critical factor in neurodegeneration and dementia.
  • Elucidating CCH mechanisms offers therapeutic targets for AD and vascular dementia.
  • Further research into CCH is essential for developing effective preventative and treatment strategies.

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.2K
An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices07:57

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices

Published on: April 11, 2018

6.6K

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
7
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
7
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
7
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
5
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
2